Procter Gamble Valuation
| PGHL Stock | 5,408 75.90 1.38% |
At this time, the company appears to be fairly valued. Procter Gamble Health holds a recent Real Value of USD5362.55 per share. The prevailing price of the company is USD5408.15. Our model determines the value of Procter Gamble Health from analyzing the company fundamentals such as Operating Margin of 0.35 %, shares outstanding of 16.6 M, and Return On Equity of 0.31 as well as examining its technical indicators and probability of bankruptcy.
Price Book 16.6788 | Enterprise Value 87.4 B | Enterprise Value Ebitda 28.9981 | Price Sales 7.8746 | Trailing PE 41.179 |
Fairly Valued
Today
Please note that Procter Gamble's price fluctuation is very steady at this time. Calculation of the real value of Procter Gamble Health is based on 3 months time horizon. Increasing Procter Gamble's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Procter stock is determined by what a typical buyer is willing to pay for full or partial control of Procter Gamble Health. Since Procter Gamble is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Procter Stock. However, Procter Gamble's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5408.15 | Real 5362.55 | Hype 5408.15 | Naive 5939.8 |
The intrinsic value of Procter Gamble's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Procter Gamble's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Procter Gamble Health helps investors to forecast how Procter stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Procter Gamble more accurately as focusing exclusively on Procter Gamble's fundamentals will not take into account other important factors: Procter Gamble Cash |
|
Procter Gamble Total Value Analysis
Procter Gamble Health is at this time projected to have takeover price of 87.41 B with market capitalization of 91.32 B, debt of 95.6 M, and cash on hands of 3.4 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Procter Gamble fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
87.41 B | 91.32 B | 95.6 M | 3.4 B |
Procter Gamble Investor Information
About 52.0% of the company outstanding shares are owned by corporate insiders. The company recorded earning per share (EPS) of 131.42. Procter Gamble Health last dividend was issued on the 28th of November 2024. Based on the measurements of operating efficiency obtained from Procter Gamble's historical financial statements, Procter Gamble Health is performing exceptionally good at this time. It has a great probability to report excellent financial results in February.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | 7.3 B | 7 B |
|
|
Procter Gamble Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Procter Gamble has an asset utilization ratio of 144.93 percent. This implies that the Company is making USD1.45 for each dollar of assets. An increasing asset utilization means that Procter Gamble Health is more efficient with each dollar of assets it utilizes for everyday operations.Procter Gamble Ownership Allocation
Procter Gamble owns a total of 16.6 Million outstanding shares. Procter Gamble has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Procter Gamble Profitability Analysis
The company reported the revenue of 11.51 B. Net Income was 2.01 B with profit before overhead, payroll, taxes, and interest of 8.28 B.About Procter Gamble Valuation
The stock valuation mechanism determines Procter Gamble's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Procter Gamble Health based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Procter Gamble. We calculate exposure to Procter Gamble's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Procter Gamble's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 9.4 B | 5.5 B |
Procter Gamble Quarterly Retained Earnings |
|
Additional Tools for Procter Stock Analysis
When running Procter Gamble's price analysis, check to measure Procter Gamble's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procter Gamble is operating at the current time. Most of Procter Gamble's value examination focuses on studying past and present price action to predict the probability of Procter Gamble's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procter Gamble's price. Additionally, you may evaluate how the addition of Procter Gamble to your portfolios can decrease your overall portfolio volatility.